• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补中益气汤对结直肠癌常规手术及化疗后脾胃气虚患者的治疗作用

Therapeutic effects of Buzhong Yiqi decoction in patients with spleen and stomach qi deficiency after routine surgery and chemotherapy for colorectal cancer.

作者信息

Hu Qi, Chen Xiao-Pin, Tang Zhi-Jun, Zhu Xue-Yuan, Liu Chun

机构信息

College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China.

Department of Anorectal Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China.

出版信息

World J Gastrointest Surg. 2024 Jul 27;16(7):2183-2193. doi: 10.4240/wjgs.v16.i7.2183.

DOI:10.4240/wjgs.v16.i7.2183
PMID:39087096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11287697/
Abstract

BACKGROUND

According to the theory of traditional Chinese medicine (TCM), the spleen and stomach are the basis of acquired nature and the source of qi and blood biochemistry. After surgery and chemotherapy, patients with colorectal cancer often develop spleen and stomach qi deficiency syndrome, leading to decreased immune function. Buzhong Yiqi decoction, a classic TCM prescription, has the effect of tonifying middle-jiao and invigorating qi, boosting Yang, and suppressing immune-related inflammation. Moreover, it is widely used in the treatment of spleen and stomach qi deficiency syndrome.

AIM

To investigate the effect of Buzhong Yiqi decoction on spleen and stomach qi deficiency in patients with colorectal cancer.

METHODS

One hundred patients with colorectal cancer who underwent preoperative chemotherapy and laparoscopy at The First TCM Hospital of Changde from January 2022 to October 2023 were retrospectively analyzed. The patients were divided equally into control and observation groups. Both groups underwent conventional rehabilitation surgery, and the observation group was supplemented with Buzhong Yiqi decoction. SPSS 26.0 was used for statistical analyses. The test was used for univariate analysis; independent sample -tests were used in all cases.

RESULTS

No significant differences were observed preoperatively in the general characteristics of the two groups. Fourteen days post-surgery, the abdominal distension, emaciation, loose stool, loss of appetite, and vomiting scores were significantly lower in the observation group than in the control group ( < 0.05). Immune function and interleukin (IL)-10 levels in the observation group were significantly higher than those of the control group, whereas IL-6, tumor necrosis factor-α, and C-reactive protein levels, tumor biological indexes, and adverse reactions in the observation group were significantly lower than those of the control group ( < 0.05). One month after surgery, the patients' quality of life in the observation group was significantly higher than that of the patients in the control group ( < 0.05).

CONCLUSION

Buzhong Yiqi decoction can regulate inflammatory responses and metabolic processes by enhancing immune function, thereby promoting overall immune nutrition and restoring the body's balance.

摘要

背景

根据中医理论,脾胃是后天之本,气血生化之源。结直肠癌患者术后及化疗后常出现脾胃气虚证,导致免疫功能下降。补中益气汤是经典的中医方剂,具有补中益气、升阳举陷、抑制免疫相关炎症的作用。此外,它还广泛用于治疗脾胃气虚证。

目的

探讨补中益气汤对结直肠癌患者脾胃气虚的影响。

方法

回顾性分析2022年1月至2023年10月在常德市第一中医医院接受术前化疗和腹腔镜手术的100例结直肠癌患者。将患者平均分为对照组和观察组。两组均接受常规康复手术,观察组加用补中益气汤。采用SPSS 26.0进行统计分析。采用检验进行单因素分析;所有病例均采用独立样本检验。

结果

两组术前一般特征无显著差异。术后14天,观察组腹胀、消瘦、大便溏薄、食欲不振和呕吐评分均显著低于对照组(<0.05)。观察组免疫功能和白细胞介素(IL)-10水平显著高于对照组,而观察组IL-6、肿瘤坏死因子-α、C反应蛋白水平、肿瘤生物学指标和不良反应显著低于对照组(<0.05)。术后1个月,观察组患者生活质量显著高于对照组(<0.05)。

结论

补中益气汤可通过增强免疫功能调节炎症反应和代谢过程,从而促进整体免疫营养,恢复机体平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/11287697/410f7925f54d/WJGS-16-2183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/11287697/682153ca02d4/WJGS-16-2183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/11287697/410f7925f54d/WJGS-16-2183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/11287697/682153ca02d4/WJGS-16-2183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fab4/11287697/410f7925f54d/WJGS-16-2183-g002.jpg

相似文献

1
Therapeutic effects of Buzhong Yiqi decoction in patients with spleen and stomach qi deficiency after routine surgery and chemotherapy for colorectal cancer.补中益气汤对结直肠癌常规手术及化疗后脾胃气虚患者的治疗作用
World J Gastrointest Surg. 2024 Jul 27;16(7):2183-2193. doi: 10.4240/wjgs.v16.i7.2183.
2
Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.补中益气汤基于扶正祛邪经典方治疗多药耐药菌医院获得性肺炎的随机对照试验研究方案。
Trials. 2019 Dec 30;20(1):817. doi: 10.1186/s13063-019-3927-x.
3
Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer.补中益气汤联合THP膀胱灌注对膀胱癌患者术后疗效的影响
Evid Based Complement Alternat Med. 2021 Nov 11;2021:3685213. doi: 10.1155/2021/3685213. eCollection 2021.
4
[Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor].补中益气汤对肺腺癌移植瘤裸鼠脾、胃及肺组织中PI3K和AKT的影响
Zhongguo Zhong Yao Za Zhi. 2014 May;39(10):1869-73.
5
[Systematic review and Meta-analysis on efficacy and safety of Buzhong Yiqi Decoction for stable chronic obstructive pulmonary disease].补中益气汤治疗稳定期慢性阻塞性肺疾病疗效及安全性的系统评价与Meta分析
Zhongguo Zhong Yao Za Zhi. 2020 Nov;45(22):5344-5355. doi: 10.19540/j.cnki.cjcmm.20200904.501.
6
Clinical remission of moderate generalized myasthenia gravis through exclusive use of Buzhong Yiqi decoction: A case report.补中益气汤专方治疗中度全身型重症肌无力的临床缓解:一例报告。
Explore (NY). 2024 Jul-Aug;20(4):588-591. doi: 10.1016/j.explore.2024.05.004. Epub 2024 May 10.
7
Study on the effect of Jianpi Yiqi decoction on clinical symptoms, inflammation, oxidative stress, efficacy and adverse reactions in sufferers with colorectal cancer.健脾益气汤对结直肠癌患者临床症状、炎症、氧化应激、疗效及不良反应的影响研究。
Biotechnol Genet Eng Rev. 2024 Dec;40(4):3019-3034. doi: 10.1080/02648725.2023.2203004. Epub 2023 Apr 21.
8
[Effects of serums containing Buzhong Yiqi decoction with Astragalus Radix or Hedysari Radix on anti-immunosenescence in spleen lymphocytes of SAMP8 mice].[含黄芪或红芪补中益气汤血清对SAMP8小鼠脾脏淋巴细胞抗免疫衰老的影响]
Zhongguo Zhong Yao Za Zhi. 2016 Aug;41(15):2888-2894. doi: 10.4268/cjcmm20161524.
9
[Effects of Buzhong Yiqi decoction on expression of Bad, NF-κB, caspase-9, Survivin, and mTOR in nude mice with A549/DDP transplantation tumors].补中益气汤对A549/DDP移植瘤裸鼠中Bad、NF-κB、caspase-9、Survivin及mTOR表达的影响
Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(4):725-730. doi: 10.19540/j.cnki.cjcmm.20161222.062.
10
Clinical Study on the Treatment of Female Stress Urinary Incontinence With Modified Buzhong Yiqi Decoction.加味补中益气汤治疗女性压力性尿失禁的临床研究
Front Surg. 2022 Apr 13;9:882621. doi: 10.3389/fsurg.2022.882621. eCollection 2022.

引用本文的文献

1
Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer.中医药在结直肠癌防治中的研究进展
World J Gastrointest Oncol. 2025 Jun 15;17(6):105690. doi: 10.4251/wjgo.v17.i6.105690.
2
Association of Sijunzi decoction plus chemotherapy with gastrointestinal function and serum markers in patients after gastric carcinoma surgery.四君子汤加化疗对胃癌术后患者胃肠功能及血清标志物的影响
World J Gastrointest Surg. 2025 Apr 27;17(4):100800. doi: 10.4240/wjgs.v17.i4.100800.
3
Investigating the PI3K/AKT/mTOR axis in Buzhong Yiqi Decoction's anti-colorectal cancer activity.

本文引用的文献

1
Laparoscopic polyglycolic acid spacer placement for locally recurrent rectal cancer.腹腔镜聚乙二醇酸间隔物放置术治疗局部复发性直肠癌。
Colorectal Dis. 2024 Apr;26(4):760-765. doi: 10.1111/codi.16882. Epub 2024 Feb 6.
2
Hartmann's procedure in rectal cancer surgery is often an intraoperative decision: a retrospective multicenter study.Hartmann 手术在直肠癌手术中通常是一个术中决策:一项回顾性多中心研究。
Langenbecks Arch Surg. 2024 Feb 7;409(1):55. doi: 10.1007/s00423-024-03237-8.
3
Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
研究补中益气汤抗结直肠癌活性中的PI3K/AKT/mTOR信号轴。
Sci Rep. 2025 Mar 10;15(1):8238. doi: 10.1038/s41598-025-89018-9.
解读非编码RNA在结直肠癌转化生长因子-β信号通路中的功能格局及治疗意义:一项综述
Pathol Res Pract. 2024 Mar;255:155158. doi: 10.1016/j.prp.2024.155158. Epub 2024 Jan 22.
4
Gut microbiota modulate CD8 T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX.肠道微生物群通过丁酸/GPR109A/HOPX 调节胃癌中的 CD8 T 细胞免疫。
Gut Microbes. 2024 Jan-Dec;16(1):2307542. doi: 10.1080/19490976.2024.2307542. Epub 2024 Feb 6.
5
Molecular pathological classification of colorectal cancer-an update.结直肠癌的分子病理分类——更新。
Virchows Arch. 2024 Feb;484(2):273-285. doi: 10.1007/s00428-024-03746-3. Epub 2024 Feb 6.
6
Precision medicine in the treatment of colorectal cancer with liver metastases.精准医学在结直肠癌肝转移治疗中的应用
Cancer Biol Med. 2024 Feb 5;20(12):942-6. doi: 10.20892/j.issn.2095-3941.2023.0483.
7
Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?新辅助放化疗后具有不利特征的直肠癌患者行机器人手术是否有益?
Ann Surg Oncol. 2024 May;31(5):3203-3211. doi: 10.1245/s10434-024-14976-9. Epub 2024 Feb 5.
8
Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma.一种用于结肠腺癌的联合免疫和癌症相关成纤维细胞相关预后特征的开发与验证
Front Immunol. 2024 Jan 19;15:1291938. doi: 10.3389/fimmu.2024.1291938. eCollection 2024.
9
Ononin promotes radiosensitivity in lung cancer by inhibiting HIF-1α/VEGF pathway.芒柄花素通过抑制HIF-1α/VEGF通路促进肺癌的放射敏感性。
Phytomedicine. 2024 Mar;125:155290. doi: 10.1016/j.phymed.2023.155290. Epub 2023 Dec 20.
10
Comparative efficacy of uncut Roux-en-Y and Billroth II anastomosis in gastrointestinal reconstruction following laparoscopic radical gastrectomy for distal gastric cancer.腹腔镜辅助远端胃癌根治术后 Roux-en-Y 吻合与 Billroth II 吻合胃肠重建的疗效比较。
Medicine (Baltimore). 2024 Feb 2;103(5):e37037. doi: 10.1097/MD.0000000000037037.